Trials To Assess Dual Antiplatelet Therapy For Combatting DES Thrombosis
Executive Summary
Chicago - Major drug-eluting stent manufacturers are negotiating to design a clinical trial to help determine the optimal time period for using dual antiplatelet therapy to avoid thrombosis in patients with a drug-eluting stent, according to Boston Scientific VP-Interventional Cardiology Marketing Eric Simso